Cancer
This page brings together the European Medicines Agency's (EMA) latest information on cancer.
It lists the following:
16 new medicines recommended for approval; another ten medicines recommended for extension of their therapeutic indications
Five new medicines recommended for approval; another seven medicines recommended for extension of their therapeutic indications
EMA’s human medicines committee (CHMP) recommended eight medicines for approval at its April 2024 meeting.
EMA’s human medicines committee (CHMP) recommended 12 medicines for approval at its March 2024 meeting.
Currently, we have no events for this therapeutic area.